Its easy for Remdesivir to demonstrate a benefit o
Post# of 148159
(Total Views: 532)
Posted On: 05/05/2020 3:21:18 PM
Re: ClosetInvestor #32054
Its easy for Remdesivir to demonstrate a benefit of 5 days vs 10 days since it's causing organ failure the longer it's used. Too bad Leronlimab has a pristine safety profile? 
Quote:
P.S. I’d like CYDY to pitch a change of primary endpoint to the FDA to 7 days and 14 days like Gilead but with hospitalizations and death rates included. This 6 week primary endpoint is garbage.
Read More: https://investorshangout.com/post/view?id=575...z6Lb3z5iAq
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼